Company Filing History:
Years Active: 2011-2012
Title: Gloria Breault: Innovator in Antibacterial Compounds
Introduction
Gloria Breault is a prominent inventor based in Waltham, MA (US), known for her significant contributions to the field of antibacterial treatments. With a total of 2 patents, she has focused her research on developing compounds that address multi-drug resistant bacterial infections, a growing concern in modern medicine.
Latest Patents
Her latest patents include innovative compounds for the treatment of multi-drug resistant bacterial infections. These inventions relate to compounds of Formula V(A) that demonstrate antibacterial activity. The patents detail processes for their preparation, pharmaceutical compositions containing these compounds as active ingredients, and their use as medicaments. Specifically, these compounds are designed for the treatment of bacterial infections in warm-blooded animals, including humans. The focus on these compounds highlights their potential in combating serious bacterial infections that are resistant to conventional treatments.
Career Highlights
Gloria Breault has made significant strides in her career, particularly through her work at AstraZeneca AB. Her research has not only contributed to the scientific community but has also paved the way for new therapeutic options in the medical field. Her dedication to innovation in antibacterial treatments showcases her commitment to improving health outcomes.
Collaborations
Throughout her career, Gloria has collaborated with notable colleagues, including Charles Joseph Eyermann and Bolin Geng. These partnerships have enhanced her research efforts and contributed to the development of her patented compounds.
Conclusion
Gloria Breault's work in developing antibacterial compounds represents a vital advancement in the fight against multi-drug resistant infections. Her contributions to the field are invaluable, and her ongoing research continues to inspire innovation in medical treatments.